Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contraceptive efficacy and safety of estetrol + drospirenone oral contraceptive
2015-003150-40Phase 3Completed
- Sponsor
- Estetra SRL
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of estetrol + drospirenone, sponsored by Estetra SRL. Primary endpoint: On-treatment pregnancies (Pearl Index, age 18–35). Started Jan 2016; status: completed.
02
Drugs
estetrol + drospirenone
Beyond the preview
Go deeper on 2015-003150-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003150-40.